News Focus
News Focus
icon url

MazelMan

01/18/14 6:49 PM

#157024 RE: Protector #157023

Sounds right obviously because of the relationship Garnick had/has with Genentech.

Going North.
icon url

sulaco

01/18/14 6:55 PM

#157025 RE: Protector #157023

Anti PD-1 antibody is a Merck product


And don't count Merck out as a potential partner.

They're on the warpath for immunostimulatory Mabs, and they have ultra-deep pockets.

You better believe they know all about Bavi, and are figuring out, as we speak, how to control it or buy it.


GLTAL!

best,

Joe
icon url

Bungler

01/19/14 10:24 AM

#157063 RE: Protector #157023

CP, permitted clinical use of a patented compound has nothing to do with whether or not it has been approved for marketing. It is expressly permitted by US Law. 35 USC 271(e) exempts all uses of compounds that are reasonably related to submission of information to the government under any law regulating the manufacture, use or distribution of drugs, from claims of patent infringement. So held the US Supreme Court in Merck KGaA v. Integra Lifesciences I, Ltd. 545 U.S. 193 (2005).

PD-1 is NOT FDA approved as was CTLA-4.

That means PPHM could not do any pre-clinical or clinical trial with PD-1 without the authorisation of the BP that owns it